Matthew Matasar, Anthony Masaquel, Carolina Reyes, Farah Hossain, Eric Zuk, Rebecca Straubing, Matthew Davis, Scott Huntington. "Real-world effectiveness of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin and prednisone (R-CHP) compared with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) among elderly Medicare beneficiaries with diffuse large B-cell lymphoma (DLBCL) in the United States." Blood, 2025. doi:10.1182/blood-2025-4486